White House admits report that listed ‘ending’ COVID pandemic as Trump accomplishment was ‘poorly worded’
The White House acknowledged on Wednesday that a report touting the “ending of the COVID-19 pandemic” as one of the Trump administration’s accomplishments was “poorly worded.”
“I think that was poorly worded,” White House communications director Alyssa Farah said on Fox News. “The intent was to say that it is our goal to end the virus.”
On Tuesday, the White House Office of Science and Technology Policy published a 62-page report outlining what it called “highlights” in “Advancing America’s Global Leadership in Science & Technology” over the past four years. The “ending of the COVID-19 pandemic” was among them.
The pandemic has not ended.
President Trump has repeatedly sought to downplay the seriousness of the virus while defending his handling of the pandemic. In the most recent Yahoo News/YouGov poll, 62 percent of Americans identified “managing COVID” as a “major failure” of the administration. Exactly half that number listed it as a “major accomplishment.”
As cases continue to surge in the Upper Midwest, including states Trump is expected to win easily, the president has complained that the media is too focused on covering the outbreak rather than his accomplishments.
“Covid, Covid, Covid is the unified chant of the Fake News Lamestream Media,” he tweeted Wednesday. “They will talk about nothing else until November 4th, when the Election will be (hopefully!) over. Then the talk will be how low the death rate is, plenty of hospital rooms, & many tests of young people.”
More than 226,000 Americans have died of complications related to COVID-19, and more than 8.6 million have been infected since the outbreak began.
And health officials in several states, including Idaho, Texas and Utah, are reporting that hospitals are at or above capacity.
Trump has also falsely said the United States is “rounding the corner” on the coronavirus. Last week the country set a new daily record for coronavirus cases, with 83,757 on Oct. 23.
On Fox, Farah tried to explain the president’s statement.
“We’re still in the midst of the pandemic,” she said. “We’re turning the corner, and what we mean by that is, we’re rushing therapeutics, we’re in the best place to treat the virus that we’ve ever been in.”
Read more from Yahoo News:
White House strategic communications director Alyssa Farah clarified a White House statement regarding the coronavirus pandemic on “America’s Newsroom.”
The White House’s science policy office was criticized for listing “ending the COVID-19 pandemic” as one of President Trump’s accomplishments in a press release, which Farah said was “poorly worded.”
“Cases are still rising and we need the American public to remain vigilant,” she said. “This is the top priority of the president, defeating this virus and rebuilding our economy. But we are rounding the corner because we think that we will have a vaccine by the end of the year, and because of the president’s leadership, we expect that we’ll be able to massively deploy that on a large scale to as many as 100 million Americans by the end of the year.”
TRUMP INSISTS US ‘ROUNDING THE TURN’ ON CORONAVIRUS PANDEMIC AT NEW HAMPSHIRE RALLY
The Office of Science and Technology Policy statement read: “From the outset of the Covid-19 pandemic, the Administration has taken decisive actions to engage scientists and health professionals in academia, industry, and government to understand, treat, and defeat the disease.”
As of Wednesday morning, the U.S. had reported more than 8,779,655 coronavirus cases and at least 226,722 deaths, as several areas of the country struggle to contain surging cases.
“Does the White House — the president — believe the virus has been defeated?” host Sandra Smith asked.
TRUMP, BIDEN CLASH OVER CORONAVIRUS REOPENING PLANS
“No, absolutely not,” Farah replied. “That was poorly worded. I think that the intent was to say that it is our goal to end the virus.”
She pointed to Trump’s leadership amid the pandemic, saying there will be more positive announcements coming soon from the White House.
CLICK HERE TO GET THE FOX NEWS APP
“We are rushing therapeutics. … We’ve got remdesivir on the market that people are able to use. We’ve got monoclonal antibodies. We’ve got steroids that are able to be used to treat the most vulnerable. We have massive testing and the ability to isolate cases,” Farah concluded. “We are in the best position to date to treat the virus than we have been at any time.”
It didn’t take very much soft drink consumption for people to see elevated risk of cardiovascular disease (CVD), a large cohort study in France suggested.
People who drank the most sugary drinks (a median 185 ml or 6.26 fl oz per day — barely half a can of ordinary soda) were more likely to experience a CVD event compared with non-consumers of these drinks (HR 1.20, 95% CI 1.04-1.40), according to a group led by Eloi Chazelas, a PhD candidate at Sorbonne Paris Nord University.
Similarly, those who drank relatively more artificially sweetened beverages (176.7 ml or 5.97 fl oz per day) had higher CVD risk over a median 6.6 years of follow-up compared with non-consumers of the drinks (HR 1.32, 95% CI 1.00-1.73), the investigators reported in a research letter online in the Journal of the American College of Cardiology.
The statistics reflected adjustment for other dietary habits, including consumption of alcohol, red and processed meats, whole grains, legumes, and fruits and vegetables, as well as overall calorie counts and comorbidities such as hypertension and type 2 diabetes.
The data suggest that artificially sweetened beverages may not be a healthy substitute for sugary drinks containing 5% or more sugar, Chazelas and colleagues concluded, noting the current debate on taxes, labeling, and regulation of both types of drinks.
The researchers noted that sugar substitutes are thought to have various metabolic effects, including gut microbiota perturbation.
For the study, the team counted first incident cases of stroke, transient ischemic attack, myocardial infarction, acute coronary syndrome, and angioplasty in the CVD endpoint.
At lower intake levels, neither sugary drinks (median 46.7 ml or 1.58 fl oz per day; HR 1.05, 95% CI 0.92-1.20) nor artificially sweetened drinks (40.0 ml or 1.35 fl oz per day; HR 1.15, 95% CI 0.94-1.42) showed a link to CVD.
The study was based on the French NutriNet-Santé cohort launched in 2009. The 104,760 people who volunteered had been asked to complete 24-hour dietary records every 6 months. The investigators linked their files to records from the French national health insurance system and the French national mortality registry.
Study participants had a mean age of 42.9 years, and 78.6% were women. Average body mass index was 23.7, and 17.2% of people were current smokers at baseline. Nearly one in three had a family history of CVD. The prevalence of type 2 diabetes was 1.4%, of high cholesterol was 8.0%, of hypertension was 8.2%, and of hypertriglyceridemia was 1.4%.
The researchers collected an average 5.7 dietary records per person over follow-up.
Study limitations, Chazelas and co-authors said, included potential residual confounding despite the adjustments for covariates. They attempted to account for reverse causality by excluding CVD events in the first 3 years of follow-up. Establishing a causal relationship between sugar substitutes and CVD will require replication in other large-scale prospective cohorts and further mechanistic investigation, the team added.